Minocycline hydrochloride as a potential adjuvant to improve osteoconductive and osteoinductive properties of bone substitutes in an extra-skeletal bone augmentation model: Preliminary observations in rats.

  • Luxembourg Center of Neuropathology
June 11, 2021 By:
  • Biewer B
  • Van Hede D
  • Rompen E
  • Mittelbronn M
  • Quatresooz P
  • Borgmann FBK.

Objectives The present study was performed to determine if minocycline HCl could influence the behavior of deproteinized bovine bone mineral (DBBM) and bioactive glass (BG) particles when used as filler material for new bone generation in a guided bone augmentation model.
Materials and Methods Two occlusive titanium caps were placed on the rat calvaria. One filled with BG particles, the second with DBBM particles, both previously mixed with blood (control). In minocycline HCl loaded groups (experimental), grafts were additionally placed into a minocycline solution. Samples were harvested after 4, 8, and 16 weeks. Half of the samples were embedded in methylmethacrylate for undecalcified histology and the other half was fixed, decalcified, and embedded in paraffin for classical histologic analysis.
Results The control groups highlighted osteoconductive and osteoinductive responses associated to BG particles, as well as an osteoconductive reaction, in DBBM sections. The addition of minocycline HCl to BG particles had no measurable influence on the result. In minocycline HCl loaded DBBM sections; however, areas of spontaneous ossification could be observed after 8 and 16 weeks.
Conclusion Our observations suggest that minocycline HCl may add some osteoinductive properties to DBBM within the limitations of this study design. Further investigations are needed to refine the present results.

2021 Jun. Eur Dent Res Biomater J.
Other information